Illustration: A.Canamucio |
![]() |
Skepticism about the NAS report is justified, but for reasons different from those the antitechnology activists ...
Illustration: A.Canamucio A long-awaited report from the National Academy of Sciences (NAS) on proposed Environmental Protection Agency (EPA) regulation of recombinant DNA-manipulated plants that was released last month has been interpreted in contradictory ways. The Washington Post reported that "crops that are genetically engineered to produce their own pesticides appear to be safe," and CBS news observed that the NAS review was "the closest thing to a seal of approval gene-altered foods have
Illustration: A.Canamucio |
![]() |
Skepticism about the NAS report is justified, but for reasons different from those the antitechnology activists ...
A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.
View this IssueIn this webinar, Ethan Shelkey and Aurita Menezes will highlight key aspects in the design of cell-based assays.
Discover how alternative animal models provide new perspectives on physiological and biochemical processes.
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
Multiomics platform streamlines workflows and provides real-time insights, optimizing resource usage and ensuring smooth, data-driven operations
Learn how to overcome the challenges of viral transduction workflows.
Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology designed to accelerate drug discovery and disease research with unprecedented scalability, reproducibility, and efficiency.
Learn how a target enrichment approach improves the discovery and characterization of viral pathogens.